ReviewInternational journal of emergency medicine2026
Takotsubo cardiomyopathy in myasthenia gravis: a systematic review of case reports with subtype-based analysis.
Review in International journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTakotsubo cardiomyopathy (TTC) is a stress-induced cardiac disorder characterized by transient left ventricular dysfunction. Myasthenia gravis (MG), an autoimmune neuromuscular disease, can precipitate TTC during exacerbations such as myasthenic crises. However, the clinical features and outcomes of TTC associated with MG remain unclear.
methodsWe conducted a systematic review by the PRISMA guidelines. A comprehensive search of PubMed, Web of Science, and Google Scholar was performed up to May 31, 2025, using terms related to TTC and MG. Case reports and series were included if they described patients with confirmed diagnoses of both MG and TTC, with MG exacerbation occurring at the time of TTC onset. Data were extracted and compared between apical and non-apical TTC subtypes. Statistical analyses included the Mann-Whitney U test and chi-squared or Fisher's exact test, as appropriate.
resultsA total of 38 articles comprising 40 cases were included. The median age was 69 years; 67.5% of the participants were female. Apical TTC was the most common subtype (71.8%). Myasthenic crisis was the most frequent TTC trigger (37.5%), while chest pain was reported in only 17.5% of cases. Mechanical ventilation and ICU admission were required in 95% and 97.4% of cases, respectively. Overall mortality was 17.5%. No significant differences were found between TTC subtypes; apical cases showed numerically higher troponin levels, which should be interpreted cautiously.
conclusionsTTC associated with MG exacerbation is a rare but serious condition with high rates of respiratory failure, ICU admission, and mortality. Emergency and critical care physicians should suspect TTC in MG patients presenting with hemodynamic instability or ECG abnormalities, even in the absence of chest pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.